Cargando…

Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis

The role of deficiency of oxoguanine glycosylase 1 (Ogg1) Mmh homolog, a repair enzyme of the 8-hydroxy-2’-deoxyguanosine (8-OHdG) residue in DNA, was investigated using the multiorgan carcinogenesis bioassay in mice. A total of 80 male and female six-week-old mice of C57BL/6J background carrying a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakehashi, Anna, Ishii, Naomi, Okuno, Takahiro, Fujioka, Masaki, Gi, Min, Wanibuchi, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578188/
https://www.ncbi.nlm.nih.gov/pubmed/28820464
http://dx.doi.org/10.3390/ijms18081801
_version_ 1783260489788162048
author Kakehashi, Anna
Ishii, Naomi
Okuno, Takahiro
Fujioka, Masaki
Gi, Min
Wanibuchi, Hideki
author_facet Kakehashi, Anna
Ishii, Naomi
Okuno, Takahiro
Fujioka, Masaki
Gi, Min
Wanibuchi, Hideki
author_sort Kakehashi, Anna
collection PubMed
description The role of deficiency of oxoguanine glycosylase 1 (Ogg1) Mmh homolog, a repair enzyme of the 8-hydroxy-2’-deoxyguanosine (8-OHdG) residue in DNA, was investigated using the multiorgan carcinogenesis bioassay in mice. A total of 80 male and female six-week-old mice of C57BL/6J background carrying a mutant Mmh allele of the Mmh/Ogg1 gene (Ogg1(−/−)) and wild type (Ogg1(+/+)) mice were administered N-diethylnitrosamine (DEN), N-methyl-N-nitrosourea (MNU), N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN), N-bis (2-hydroxypropyl) nitrosamine (DHPN) and 1,2-dimethylhydrazine dihydrochloride (DMH) (DMBDD) to induce carcinogenesis in multiple organs, and observed up to 34 weeks. Significant increase of lung adenocarcinomas incidence was observed in DMBDD-treated Ogg1(−/−) male mice, but not in DMBDD-administered Ogg1(+/+) animals. Furthermore, incidences of lung adenomas were significantly elevated in both Ogg1(−/−) males and females as compared with respective Ogg1(−/−) control and DMBDD-treated Ogg1(+/+) groups. Incidence of total liver tumors (hepatocellular adenomas, hemangiomas and hemangiosarcomas) was significantly higher in the DMBDD-administered Ogg1(−/−) males and females. In addition, in DMBDD-treated male Ogg1(−/−) mice, incidences of colon adenomas and total colon tumors showed a trend and a significant increase, respectively, along with significant rise in incidence of simple hyperplasia of the urinary bladder, and a trend to increase for renal tubules hyperplasia in the kidney. Furthermore, incidence of squamous cell hyperplasia in the forestomach of DMBDD-treated Ogg1(−/−) male mice was significantly higher than that of Ogg1(+/+) males. Incidence of small intestine adenomas in DMBDD Ogg1(−/−) groups showed a trend for increase, as compared to the wild type mice. The current results demonstrated increased susceptibility of Ogg1 mutant mice to the multiorgan carcinogenesis induced by DMBDD. The present bioassay could become a useful tool to examine the influence of various targets on mouse carcinogenesis.
format Online
Article
Text
id pubmed-5578188
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-55781882017-09-05 Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis Kakehashi, Anna Ishii, Naomi Okuno, Takahiro Fujioka, Masaki Gi, Min Wanibuchi, Hideki Int J Mol Sci Article The role of deficiency of oxoguanine glycosylase 1 (Ogg1) Mmh homolog, a repair enzyme of the 8-hydroxy-2’-deoxyguanosine (8-OHdG) residue in DNA, was investigated using the multiorgan carcinogenesis bioassay in mice. A total of 80 male and female six-week-old mice of C57BL/6J background carrying a mutant Mmh allele of the Mmh/Ogg1 gene (Ogg1(−/−)) and wild type (Ogg1(+/+)) mice were administered N-diethylnitrosamine (DEN), N-methyl-N-nitrosourea (MNU), N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN), N-bis (2-hydroxypropyl) nitrosamine (DHPN) and 1,2-dimethylhydrazine dihydrochloride (DMH) (DMBDD) to induce carcinogenesis in multiple organs, and observed up to 34 weeks. Significant increase of lung adenocarcinomas incidence was observed in DMBDD-treated Ogg1(−/−) male mice, but not in DMBDD-administered Ogg1(+/+) animals. Furthermore, incidences of lung adenomas were significantly elevated in both Ogg1(−/−) males and females as compared with respective Ogg1(−/−) control and DMBDD-treated Ogg1(+/+) groups. Incidence of total liver tumors (hepatocellular adenomas, hemangiomas and hemangiosarcomas) was significantly higher in the DMBDD-administered Ogg1(−/−) males and females. In addition, in DMBDD-treated male Ogg1(−/−) mice, incidences of colon adenomas and total colon tumors showed a trend and a significant increase, respectively, along with significant rise in incidence of simple hyperplasia of the urinary bladder, and a trend to increase for renal tubules hyperplasia in the kidney. Furthermore, incidence of squamous cell hyperplasia in the forestomach of DMBDD-treated Ogg1(−/−) male mice was significantly higher than that of Ogg1(+/+) males. Incidence of small intestine adenomas in DMBDD Ogg1(−/−) groups showed a trend for increase, as compared to the wild type mice. The current results demonstrated increased susceptibility of Ogg1 mutant mice to the multiorgan carcinogenesis induced by DMBDD. The present bioassay could become a useful tool to examine the influence of various targets on mouse carcinogenesis. MDPI 2017-08-18 /pmc/articles/PMC5578188/ /pubmed/28820464 http://dx.doi.org/10.3390/ijms18081801 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kakehashi, Anna
Ishii, Naomi
Okuno, Takahiro
Fujioka, Masaki
Gi, Min
Wanibuchi, Hideki
Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis
title Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis
title_full Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis
title_fullStr Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis
title_full_unstemmed Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis
title_short Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis
title_sort enhanced susceptibility of ogg1 mutant mice to multiorgan carcinogenesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578188/
https://www.ncbi.nlm.nih.gov/pubmed/28820464
http://dx.doi.org/10.3390/ijms18081801
work_keys_str_mv AT kakehashianna enhancedsusceptibilityofogg1mutantmicetomultiorgancarcinogenesis
AT ishiinaomi enhancedsusceptibilityofogg1mutantmicetomultiorgancarcinogenesis
AT okunotakahiro enhancedsusceptibilityofogg1mutantmicetomultiorgancarcinogenesis
AT fujiokamasaki enhancedsusceptibilityofogg1mutantmicetomultiorgancarcinogenesis
AT gimin enhancedsusceptibilityofogg1mutantmicetomultiorgancarcinogenesis
AT wanibuchihideki enhancedsusceptibilityofogg1mutantmicetomultiorgancarcinogenesis